Ramucirumab Interactions
There are 141 drugs known to interact with ramucirumab, along with 8 disease interactions. Of the total drug interactions, 100 are major, and 41 are moderate.
- View all 141 medications that may interact with ramucirumab
- View ramucirumab disease interactions (8)
Most frequently checked interactions
View interaction reports for ramucirumab and the medicines listed below.
- Abilify (aripiprazole)
- Activated Charcoal (charcoal)
- Aranesp (darbepoetin alfa)
- Arnuity Ellipta (fluticasone)
- Benadryl (diphenhydramine)
- BiferaRx (multivitamin with iron)
- Calcium 600 D (calcium / vitamin d)
- Cardura (doxazosin)
- Centrum Adults (multivitamin with minerals)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Coenzyme Q10 (ubiquinone)
- Compazine (prochlorperazine)
- Copper (copper gluconate)
- CoQ10 (ubiquinone)
- DuoNeb (albuterol / ipratropium)
- Effexor XR (venlafaxine)
- Eliquis (apixaban)
- Emergen-C (multivitamin with minerals)
- Ethyl Alcohol (ethanol)
- Feraheme (ferumoxytol)
- Glycerin Suppositories Maximum Strength (glycerin)
- Glycerol (glycerin)
- Heparin Sodium (heparin)
- Horizant (gabapentin enacarbil)
- Hydrea (hydroxyurea)
- Retinol (vitamin a topical)
- Rutin (bioflavonoids)
- Sotalol Hydrochloride AF (sotalol)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
Ramucirumab disease interactions
There are 8 disease interactions with ramucirumab which include:
- bleeding
- GI perforation
- hypothyroidism
- liver dysfunction
- hypertension
- PRES
- proteinuria
- thromboembolic disorders
Report options
QR code containing a link to this page
More about ramucirumab
- ramucirumab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: VEGF/VEGFR inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
